1.A. Meyer, J. Auernheimer, A. Modlinger and H. Kessler
Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting
Current Pharmaceutical Design Volume: 12 Issue Number: 22 Page: 2723 - 2747
- DOI:
http://dx.doi.org/10.2174/138161206777947740
2. Ming Hong Ni, Emiliano Esposito, Massimo Castorina and Alma Dal Pozzo
Novel RGD Peptidomimetics Embedding 1,2,3-Triazole as Central Scaffold; Synthesis and αvβ3 Integrin Affinity
Letters in Drug Design & Discovery Volume: 8 Issue Number: 5 First Page: 401 405
- DOI:
http://dx.doi.org/10.2174/157018011795514258
Development of RGD-Based Radiotracers for Tumor Imaging and Therapy: Translating from Bench to Bedside
Current Molecular Medicine Volume: 13 Issue Number: 10 Page: 1487 1505
- DOI:
http://dx.doi.org/10.2174/1566524013666131111115347
Tumor Targeting with RGD Peptide Ligands-Design of New Molecular Conjugates for Imaging and Therapy of Cancers
Anti-Cancer Agents in Medicinal Chemistry Volume: 7 Issue Number: 5 Page: 552 558
- DOI:
http://dx.doi.org/10.2174/187152007781668706
5. U. Tateishi, T. Oka and T. Inoue
Radiolabeled RGD Peptides as Integrin alpha(v)beta3–targeted PET Tracers
Current Medicinal Chemistry Volume: 19 Issue Number: 20 Page: 3301 3309
- DOI:
http://dx.doi.org/10.2174/092986712801215937
Angiogenesis Imaging Using 68Ga-RGD PET: Preliminary Report from Seoul National University Hospital
Current Medical Imaging Reviews Volume: 6 Issue Number: 1 First Page: 56 59
- DOI:
http://dx.doi.org/10.2174/157340510790694009